4.2 Article

The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen

Journal

EXPERIMENTAL PARASITOLOGY
Volume 132, Issue 4, Pages 403-409

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.exppara.2012.09.001

Keywords

Vaccination; rgp63; Liposome; Particle size; Leishmaniasis

Categories

Funding

  1. Biotechnology Research Center
  2. Mashhad University of Medical Sciences (MUMS)
  3. Center for Research and Training in Skin Diseases and Leprosy
  4. Tehran University of Medical Sciences (TUMS)
  5. Nanotechnology Research Center

Ask authors/readers for more resources

To develop an efficient liposomal vaccine delivery system, the size of liposomes is critical to their adjuvant activities. In the present study, liposomes with different sizes (100, 400, 1000 nm) containing recombinant major surface glycoprotein of Leishmania (rgp63) were prepared, characterized, and inoculated subcutaneously into BALB/c mice to evaluate the rate of protection and the type of immune response generated against leishmaniasis. The lowest footpad lesion size and splenic parasite burden were seen in the mice immunized with large size (>= 400 nm) liposomes after challenge with Leishmania major. The production of IFN-gamma was only elevated in the spleen cells of mice immunized with large size (>= 400 nm) liposomes. The highest IgG2a/IgG1 ratio was also seen in the sera of the mice immunized with large size (>= 400 nm) liposomes before and 14 weeks after challenge. The results showed that immunization with small size (100 nm) liposomes induces a Th2 response, whereas immunization with large size (>= 400 nm) liposomes induces a Th1 type of immune response. There was no significant difference in the type of induced immune response between the mice immunized with liposomes of 400 nm and those immunized with liposomes of 1000 nm or unextruded. The results of the current study demonstrated that the size of liposomes plays a significant role in the type of generated immune response. (c) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available